blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4218794

EP4218794 - IMMUNOLOGICAL TARGETING OF PATHOLOGICAL TAU PROTEINS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  15.03.2024
Database last updated on 01.01.2025
FormerThe application has been published
Status updated on  30.06.2023
Most recent event   Tooltip13.04.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
New York University
70 Washington Square
New York City, NY 10012 / US
[2023/31]
Inventor(s)01 / SIGURDSSON, Einar M
Scardsdale, 10583 / US
 [2023/31]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2023/31]
Application number, filing date23159184.310.06.2010
[2023/31]
Priority number, dateUS200918589509P10.06.2009         Original published format: US 18589509 P
[2023/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4218794
Date:02.08.2023
Language:EN
[2023/31]
Type: A3 Search report 
No.:EP4218794
Date:13.09.2023
Language:EN
[2023/37]
Search report(s)(Supplementary) European search report - dispatched on:EP11.08.2023
ClassificationIPC:A61K38/17, C07K14/47, A61K39/395, A61P25/28, G01N33/53
[2023/31]
CPC:
C07K16/18 (EP,CN,EA,US); A61K39/0005 (EP,CN,EA,US); A61K39/0007 (EP,CN,EA,US);
A61K39/39 (CN); A61K39/395 (CN); A61K39/3955 (EA,US);
A61P21/00 (EP); A61P21/02 (EP); A61P21/04 (EP);
A61P25/00 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P37/04 (EP); A61P43/00 (EP);
C07K14/4711 (CN); G01N33/6896 (EP,CN,EA,US); A61K2039/505 (EP,EA,US);
A61K2039/507 (CN,EA,US); C07K2317/20 (EA,US); C07K2317/76 (EA,US);
G01N2800/2821 (EP,CN,EA,US); Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2024/16]
Former [2023/31]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:IMMUNOLOGISCHES TARGETING PATHOLOGISCHER TAU-PROTEINE[2023/31]
English:IMMUNOLOGICAL TARGETING OF PATHOLOGICAL TAU PROTEINS[2023/31]
French:CIBLAGE IMMUNOLOGIQUE DE PROTÉINES TAU PATHOLOGIQUES[2023/31]
Examination procedure12.03.2024Amendment by applicant (claims and/or description)
12.03.2024Examination requested  [2024/16]
12.03.2024Date on which the examining division has become responsible
Parent application(s)   TooltipEP10786852.3  / EP2440234
EP17197129.4  / EP3329932
Fees paidRenewal fee
06.06.2023Renewal fee patent year 03
06.06.2023Renewal fee patent year 04
06.06.2023Renewal fee patent year 05
06.06.2023Renewal fee patent year 06
06.06.2023Renewal fee patent year 07
06.06.2023Renewal fee patent year 08
06.06.2023Renewal fee patent year 09
06.06.2023Renewal fee patent year 10
06.06.2023Renewal fee patent year 11
06.06.2023Renewal fee patent year 12
06.06.2023Renewal fee patent year 13
14.06.2023Renewal fee patent year 14
12.04.2024Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]JPH04270300  ;
 [XI]WO9822120  (WISTAR INST [US], et al);
 [XDI]US2008050383  (SIGURDSSON EINAR [US], et al);
 [E]WO2010115843  (AC IMMUNE SA [CH], et al);
 [E]WO2011013034  (PFIZER VACCINES LLC [US], et al);
by applicantUS4816567
 WO9014837
 US5059421
 WO9306223
 WO9307283
 WO9307282
 US5328470
 US5516637
 US5545807
 US5545806
 US5569825
 US5625126
 US5631237
 US5633425
 US5643599
 US5653996
 US5661016
 US5750373
 US5849586
 US5871727
 US5885613
 US5885808
 US5981225
 US5994132
 US6001557
 US6033908
 US6057155
 WO02096350
 US2003068325
 US2003104402
 US6906169
 US2005276800
 US2007082043
 US2008050383
 WO2008070363
 US19950611858
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.